Evaluating Rituximab's Impact in Follicular Lymphoma Treatment

This week, we continue our conversation on follicular lymphoma, this time focusing on front line therapy. We discuss how we approach localized and diffuse disease and the data behind why we do what we do.

Episode contents:

- What is the front-line approach to management for localized follicular lymphoma?

- What about diffuse disease in a patient who is asymptomatic? What is the front-line options there?

- What is the front-line management for patients with diffuse disease who are symptomatic?

**** Get paid to participate in market research surveys: https://affiliatepanel.members-only.online/FOC_24?utm_campaign=FOC&utm_source=email&utm_medium=email

** Want to review the show notes for this episode and others? Check out our website: https://www.thefellowoncall.com/our-episodes

Love what you hear? Tell a friend and leave a review on our podcast streaming platforms!

Twitter: @TheFellowOnCall

Instagram: @TheFellowOnCall

Listen in on: Apple Podcast, Spotify, and Google Podcast